Squarepoint’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,727
Closed -$374K 3944
2021
Q1
$374K Buy
7,727
+7,136
+1,207% +$415K ﹤0.01% 2246
2020
Q4
$58K Sell
591
-944
-61% -$82.7K ﹤0.01% 2795
2020
Q3
$106K Buy
+1,535
New +$134K ﹤0.01% 2276
2020
Q2
Sell
-1,940
Closed -$172K 2626
2020
Q1
$172K Sell
1,940
-3,165
-62% -$377K ﹤0.01% 1526
2019
Q4
$583K Buy
+5,105
New +$384K ﹤0.01% 1676
2019
Q3
Sell
-1,765
Closed -$138K 2791
2019
Q2
$138K Buy
+1,765
New +$200K ﹤0.01% 2175
2018
Q4
Sell
-2,662
Closed -$279K 2343
2018
Q3
$279K Sell
2,662
-270
-9% -$25.7K ﹤0.01% 1575
2018
Q2
$293K Sell
2,932
-476
-14% -$53.9K ﹤0.01% 1385
2018
Q1
$429K Sell
3,408
-230
-6% -$35.9K 0.01% 1150
2017
Q4
$608K Buy
+3,638
New +$932K 0.01% 1087
2017
Q3
Sell
-1,520
Closed -$451K 1972
2017
Q2
$451K Buy
1,520
+925
+155% +$247K 0.01% 999
2017
Q1
$137K Sell
595
-575
-49% -$99.3K ﹤0.01% 1362
2016
Q4
$76K Buy
+1,170
New +$73.1K ﹤0.01% 1661
2016
Q1
Sell
-585
Closed -$90K 1532
2015
Q4
$90K Buy
+585
New +$87.7K 0.01% 1147

Other funds holding CALA

Squarepoint's CALA Position: Q2 2021 in Review

Squarepoint sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 7,727 shares — an estimated $374K sold.

Squarepoint first reported a position in CALA in Q4 2015 and held it in 14 quarters. The position peaked at $608K in Q4 2017. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Squarepoint reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 7,727 Calithera Biosciences, Inc shares in Q2 2021, an estimated $374K.
  • Squarepoint first reported a position in Calithera Biosciences, Inc in Q4 2015 and held it in 14 quarters.
  • Squarepoint's Calithera Biosciences, Inc position peaked at $608K in Q4 2017.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.